Chris Krueger Email and Phone Number

Chris is the Chief Operating Officer at Endeavor BioMedicines.Chris brings almost 25 years of experience in the life science industry with operational responsibility and leadership for multiple functional areas, including business and corporate development, legal affairs and intellectual property, accounting and finance, human resources, alliance management and operations.Chris has negotiated a broad range of equity and debt financings, strategic partnerships, mergers and acquisitions and licensing transactions.Chris was a founder and executive officer at Ventyx Biosciences (Nasdaq: VTYX), Oppilan Pharma, Zomagen Biosciences, Escalier Biosciences, Vimalan Biosciences and Akarna Therapeutics (acquired by Allergan). Previously, he was an executive officer at Ardea Biosciences (acquired by AstraZeneca), Xencor (Nasdaq: XNCR), X-Ceptor Therapeutics (acquired by Exelixis) and Aurora Biosciences (acquired by Vertex Pharmaceuticals). Earlier in his career, he was a corporate lawyer at Cooley LLP representing emerging technology companies.Chris received a JD and MBA in Finance from the University of Southern California and a BA in Economics from the University of California, San Diego.